This is the online version of STAT’s email newsletter Health Care Inc, delivered to your inbox every Monday. Sign up here. The explosion of ‘value-based care’
A cancer therapy that prompts the body’s immune defenses against viruses and bacteria to attack tumors can make patients more vulnerable to heart attack and
SARASOTA, FL, Nov. 29, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing
Research reveals a significant association between premature ovarian insufficiency and autoimmune diseases, highlighting hypothyroidism as a common condition.
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! I hope you had a
Findings show that within-host MTBC variation improves transmission inference, suggesting new strategies for understanding and controlling tuberculosis spread.
The study reveals IL-15’s role in enhancing GPC3 CAR T cell therapy, improving tumor targeting and T cell survival in patients with solid cancers.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! Hope you had
Good morning, everyone, and welcome to another working week. We hope the weekend respite — which was extended for many on our side of the
Fate Therapeutics’ current president of research and development, Bob Valamehr, will take over as president and CEO effective from 1 January 2025. Credit: Piotr Swat/Shutterstock.